-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DXiy1d/KFETZNncfAeC6esAZq9vAt8MEgqLHCW5Ecdz0U2nlZex/vx9mMsA4Pl2S jzXlIVWw1cVwGP75nMiiNw== 0000930661-01-000302.txt : 20010213 0000930661-01-000302.hdr.sgml : 20010213 ACCESSION NUMBER: 0000930661-01-000302 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-44057 FILM NUMBER: 1531876 BUSINESS ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BARROW HANLEY MEWHINNEY & STRAUSS INC CENTRAL INDEX KEY: 0000313028 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 752403190 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 3232 MCKINNEY AVE STREET 2: 5TH FLOOR CITY: DALLAS STATE: TX ZIP: 75204-2429 BUSINESS PHONE: 2146651900 MAIL ADDRESS: STREET 1: 3232 MCKINNEY AVE STREET 2: 15TH FLOOR CITY: DALLAS STATE: TX ZIP: 75204-2429 SC 13G 1 0001.txt SCHEDULE 13G =============================================================================== IRS # 953872914 CIK # 0000884629 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* WATSON PHARMACEUTICALS - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 942683103 ------------------------------ (CUSIP Number) December 31, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 =============================================================================== CUSIP NO. 942683103 ------------- Barrow, Hanley, Mewhinney & Strauss - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS. 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). 752403190 - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 a Nevada Corporation - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 399,100 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 4,435,800 ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 4,834,900 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 4,834,900 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11 5.02% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 1A - ------------------------------------------------------------------------------ Page 2 of 4 =============================================================================== Item 1 (a) Name of Issuer Watson Pharmaceuticals (b) Address of Issuer's Principal Executive Offices 311 Bonnie Circle Corona, Ca. 92800 Item 2 (a) Name of Person Filing Barrow, Hanley, Mewhinney & Strauss (b) Address of Principal Business Office or, if none, Residence One McKinney Plaza 3232 McKinney Avenue 15th Floor Dallas, TX 75204-2429 (c) Citizenship a Nevada Corporation (d) Title of Class of Securities Common Stock (e) CUSIP Number 942683103 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b): The reporting person is an Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 4,834,900 (b) Percent of class: 5.02% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 399,100 (ii) Shared power to vote or to direct the vote 4,834,900 (iii) Sole power to dispose or to direct the disposition of 4,834,900 (iv) Shared power to dispose or to direct the disposition of Instruction. For computations regarding securities which represent a right to acquire an underlying security see (S)240.13d-3(d)(1). Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Instruction: Dissolution of a group requires a response to this item. Page 3 of 4 =============================================================================== Item 6. Ownership of More than Five Percent on Behalf of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item, and if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of the employee benefit plan, pension fund or endowment fund is not required. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Item 8. Identification and Classification of Members of the Group. If a group has filed this schedule pursuant to (S)240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to (S)240.13d-1(c) or (S)240.13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of a Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certification By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Barrow, Hanley, Mewhinney & Strauss, Inc. By: /s/ James P. Barrow ------------------------------------ Signature February 12, 2001 James P. Barrow / President ---------------------------------- Name/Title Page 4 of 4 -----END PRIVACY-ENHANCED MESSAGE-----